金币
UID308908
帖子
主题
积分516
注册时间2017-7-25
最后登录1970-1-1
听众
性别保密
|
楼主 |
发表于 2017-8-9 08:58:23
|
显示全部楼层
你说的是FDA的分析方法验证指南吗?这个中只有一小段内容,我已经看过了,如下:
Degradation information obtained from stress studies (e.g., products of acid and base hydrolysis, thermal degradation,photolysis, oxidation) for the drug substance and for the active ingredient in the drug product should be provided to demonstrate the specificity of the assay and analytical procedures for impurities. The stress studies should demonstrate that impurities and degradants from the active ingredient and drug product excipients do not interfere with the quantitation of the active ingredient. Stress studies are described in various FDA guidances relating to the stability of drug products (see references). The design of the stress studies and the results should be submitted to the stability section of the application. Representative instrument output (e.g., chromatograms) and/or other appropriate data (e.g., degradation information obtained from stress studies) should be submitted in the sections on analytical procedures and controls. |
|